Literature DB >> 3559542

Studies in postmortem dopamine uptake. II. Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia.

N Haberland, L Hetey.   

Abstract

Kinetic parameters KM and Vmax of the synaptosomal high-affinity dopamine (DA) and noradrenaline (NA) uptake were measured in the nucleus (n.) accumbens, n. caudatus and frontal cortex from post-mortem brains of schizophrenic patients and matched controls. Additionally, the 5-hydroxytryptamine (5 HT) uptake was determined in the n. accumbens of the same specimens. The KM and Vmax data of DA uptake were significantly elevated in the n. accumbens (KM to 253%, Vmax to 271%) and in the n. caudatus (KM to 201%, Vmax to 174%) of schizophrenics in comparison with controls. The kinetic parameters of the NA uptake increased similarly in the n. accumbens and n. caudatus of schizophrenics in comparison with controls. The alterations in DA and NA uptake kinetics do not seem to be primarily dependent on neuroleptic medication. On the other hand, DA and NA uptake in the frontal cortex as well as 5 HT uptake in the n. accumbens was unchanged. The results are compatible with the hypothesis that both DA and NA transmission systems are changed in schizophrenia. They give a first indication of presynaptic functional alterations in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559542     DOI: 10.1007/BF02098505

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  8 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.

Authors:  A J Cross; T J Crow; I N Ferrier; E C Johnstone; R M McCreadie; F Owen; D G Owens; M Poulter
Journal:  J Neural Transm Suppl       Date:  1983

Review 3.  Schizophrenia: some current neurochemical approaches.

Authors:  R Rodnight
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

4.  Brain catecholamines in schizophrenia -- a good case for noradrenaline.

Authors:  O Hornykiewicz
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

5.  Presynaptic dopamine and serotonin receptors modulating tyrosine hydroxylase activity in synaptosomes of the nucleus accumbens of rats.

Authors:  L Hetey; V S Kudrin; A Y Shemanow; K S Rayevsky; W Oelssner
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

6.  Studies in postmortem dopamine uptake. I. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake.

Authors:  N Haberland; L Hetey
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  Increased brain dopamine and dopamine receptors in schizophrenia.

Authors:  A V Mackay; L L Iversen; M Rossor; E Spokes; E Bird; A Arregui; I Creese; S H Synder
Journal:  Arch Gen Psychiatry       Date:  1982-09

8.  Characterization of the synaptosomal high-affinity uptake of noradrenaline in the nucleus accumbens of rats.

Authors:  L Hetey; B Zimmermann
Journal:  Biomed Biochim Acta       Date:  1986
  8 in total
  10 in total

Review 1.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

2.  Postmortem- and cryostability of the potassium-evoked release of [3H]5-hydroxytryptamine from rat cerebral cortical miniprisms.

Authors:  C J Fowler; G Thorell; I Fagervall
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells.

Authors:  Ashley L Green; Muhammad M Hossain; Siew C Tee; Helmut Zarbl; Grace L Guo; Jason R Richardson
Journal:  Neurochem Res       Date:  2015-05-12       Impact factor: 3.996

4.  Diminished synaptosomal dopamine (DA) release and DA autoreceptor supersensitivity in schizophrenia.

Authors:  L Hetey; R Schwitzkowsky; T Ott; H Barz
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.

Authors:  J Kornhuber; P Riederer; G P Reynolds; H Beckmann; K Jellinger; E Gabriel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Studies in postmortem dopamine uptake. I. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake.

Authors:  N Haberland; L Hetey
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia.

Authors:  C Czudek; G P Reynolds
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 8.  The Study of Postmortem Human Synaptosomes for Understanding Alzheimer's Disease and Other Neurological Disorders: A Review.

Authors:  Jia-Fong Jhou; Hwan-Ching Tai
Journal:  Neurol Ther       Date:  2017-07-21

9.  Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's Disease.

Authors:  Sarah Plum; Britta Eggers; Stefan Helling; Markus Stepath; Carsten Theiss; Renata E P Leite; Mariana Molina; Lea T Grinberg; Peter Riederer; Manfred Gerlach; Caroline May; Katrin Marcus
Journal:  Cells       Date:  2020-12-02       Impact factor: 6.600

Review 10.  Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.

Authors:  I Bonoldi; O D Howes
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.